Yagi M - Search Results

1

A prostaglandin D2 metabolite is elevated in the urine of Duchenne muscular dystrophy patients and increases further from 8 years old.

Nakagawa T, Takeuchi A, Kakiuchi R, Lee T, Yagi M, Awano H, Iijima K, Takeshima Y, Urade Y, Matsuo M. Nakagawa T, et al. Among authors: yagi m. Clin Chim Acta. 2013 Aug 23;423:10-4. doi: 10.1016/j.cca.2013.03.031. Epub 2013 Apr 19. Clin Chim Acta. 2013. PMID: 23603101

2

Oligonucleotides against a splicing enhancer sequence led to dystrophin production in muscle cells from a Duchenne muscular dystrophy patient.

Takeshima Y, Wada H, Yagi M, Ishikawa Y, Ishikawa Y, Minami R, Nakamura H, Matsuo M. Takeshima Y, et al. Among authors: yagi m. Brain Dev. 2001 Dec;23(8):788-90. doi: 10.1016/s0387-7604(01)00326-6. Brain Dev. 2001. PMID: 11720794 No abstract available.

3

A novel cryptic exon in intron 3 of the dystrophin gene was incorporated into dystrophin mRNA with a single nucleotide deletion in exon 5.

Suminaga R, Takeshima Y, Adachi K, Yagi M, Nakamura H, Matsuo M. Suminaga R, et al. Among authors: yagi m. J Hum Genet. 2002;47(4):196-201. doi: 10.1007/s100380200023. J Hum Genet. 2002. PMID: 12166656

4

[Dystrophin gene analysis on 76 families with dystrophinopathy].

Adachi K, Yagi M, Ito T, Takeshima Y, Nishio H, Wada H, Nakamura H, Matsuo M. Adachi K, et al. Among authors: yagi m. No To Hattatsu. 2002 Sep;34(5):391-7. No To Hattatsu. 2002. PMID: 12233050 Japanese.

5

Heterogous dystrophin mRNA produced by a novel splice acceptor site mutation in intermediate dystrophinopathy.

Adachi K, Takeshima Y, Wada H, Yagi M, Nakamura H, Matsuo M. Adachi K, et al. Among authors: yagi m. Pediatr Res. 2003 Jan;53(1):125-31. doi: 10.1203/00006450-200301000-00021. Pediatr Res. 2003. PMID: 12508091

6

Two alternative exons can result from activation of the cryptic splice acceptor site deep within intron 2 of the dystrophin gene in a patient with as yet asymptomatic dystrophinopathy.

Yagi M, Takeshima Y, Wada H, Nakamura H, Matsuo M. Yagi M, et al. Hum Genet. 2003 Feb;112(2):164-70. doi: 10.1007/s00439-002-0854-8. Epub 2002 Oct 31. Hum Genet. 2003. PMID: 12522557

7

Analysis of dystrophin mRNA from skeletal muscle but not from lymphocytes led to identification of a novel nonsense mutation in a carrier of Duchenne muscular dystrophy.

Ito T, Takeshima Y, Yagi M, Kamei S, Wada H, Nakamura H, Matsuo M. Ito T, et al. Among authors: yagi m. J Neurol. 2003 May;250(5):581-7. doi: 10.1007/s00415-003-1040-1. J Neurol. 2003. PMID: 12736738

8

[Treatment of Duchenne muscular dystrophy with gentamicin].

Matsuo M, Takeshima Y, Yagi M, Ishibashi K, Wada H. Matsuo M, et al. Among authors: yagi m. No To Hattatsu. 2004 Mar;36(2):125-9. No To Hattatsu. 2004. PMID: 15031986 Review. Japanese.

9

Chimeric RNA and 2'-O, 4'-C-ethylene-bridged nucleic acids have stronger activity than phosphorothioate oligodeoxynucleotides in induction of exon 19 skipping in dystrophin mRNA.

Yagi M, Takeshima Y, Surono A, Takagi M, Koizumi M, Matsuo M. Yagi M, et al. Oligonucleotides. 2004 Spring;14(1):33-40. doi: 10.1089/154545704322988030. Oligonucleotides. 2004. PMID: 15104894

10

Novel double-deletion mutations of the OFD1 gene creating multiple novel transcripts.

Morisawa T, Yagi M, Surono A, Yokoyama N, Ohmori M, Terashi H, Matsuo M. Morisawa T, et al. Among authors: yagi m. Hum Genet. 2004 Jul;115(2):97-103. doi: 10.1007/s00439-004-1139-1. Epub 2004 Jun 2. Hum Genet. 2004. PMID: 15221448

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,431 results

Search Page

Filters